Carl read theCarl’s one-liner: The appetite switch, with a gut-support co-pilot.
The combo
SemaglutideGLP-1 agonist — appetite suppressionRead guide →
BPC-157Gut-protective peptide — eases GI side-effectsRead guide →
Why run them together
The #1 reason people stop a GLP-1 is nausea and GI upset. BPC-157 — which started life as a gut-protective compound — is commonly added to take the edge off, so you can stay on a dose long enough for it to work.
It’s a ‘tolerability’ stack more than a ‘more weight loss’ stack: the goal is to make the GLP-1 sustainable.
Running it together
Community-reported dosing & timing for the pair (Reddit & forums) — logged for education, not a recommendation to use:
| Component | Community protocol |
|---|---|
| Semaglutide | Microdose/titrated weekly (0.05–0.25 mg to start; go low & slow) |
| BPC-157 | 250–500 mcg daily — oral is common here (gut focus) |
| Cycle | BPC in 4–8 week blocks alongside the GLP-1 |
| Timing | Semaglutide weekly; BPC daily |
The synergy
- GLP-1 controls appetite; BPC-157 buffers the stomach.
- Better tolerability = you actually stay on the effective dose.
- Oral BPC lands right where the GI side-effects are.
Cautions: Semaglutide is a prescription drug; BPC-157 is an unapproved research chemical. This eases side-effects — it doesn’t make GLP-1s risk-free. Titrate under medical guidance and prioritise protein + electrolytes (see the GLP-1 Nutrients guide).
Who it’s for
GLP-1 users who keep quitting because of nausea. As always: read each compound’s full guide, and talk to a clinician before running anything.
